SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-13-034125
Filing Date
2013-06-10
Accepted
2013-06-10 16:41:55
Documents
6
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10K v347391_10ka.htm 10-K/A 31359
2 EXHIBIT 10.37 v347391_ex10-37.htm EX-10.37 509249
3 EXHIBIT 31.1 v347391_ex31-1.htm EX-31.1 10780
4 EXHIBIT 31.2 v347391_ex31-2.htm EX-31.2 10480
5 EXHIBIT 32.1 v347391_ex32-1.htm EX-32.1 3542
6 EXHIBIT 32.2 v347391_ex32-2.htm EX-32.2 3527
  Complete submission text file 0001144204-13-034125.txt   570231
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32639 | Film No.: 13903880
SIC: 2834 Pharmaceutical Preparations